John R. Beaver is President at BIOLASE, INC (BIOL). They have made 5 open-market trades across 1 company since 2018, most recently 2022-04-28.
CIK 0001215999
5 open-market purchases totalling $126K since 2018, never a sale. Across 5 scored buys the stock is up 7.6% at ninety days, and 6.4 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BIOL | 621,530 | $80K |
Shares reported on the most recent Form 4, priced at the 2021-12-02 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 60% | 20% |
| Avg Move | -3.3% | +2.7% | +7.6% |
| Alpha | -3.5% | +3.0% | +6.4% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BIOL | BUY | 2021-11-30 | 2021-12-02 | $0.45 | $32K | -11.2% | -3.0% | -21.0% |
| BIOL | BUY | 2021-08-20 | 2021-08-23 | $0.61 | $21K | +7.1% | -3.5% | -37.0% |
| BIOL | BUY | 2021-05-19 | 2021-05-19 | $0.75 | $30K | +0.8% | +2.3% | -7.5% |
| BIOL | BUY | 2018-12-03 | 2018-12-06 | $1.18 | $1K | -6.6% | +0.9% | +131.9% |
| BIOL | BUY | 2018-08-15 | 2018-08-17 | $1.67 | $42K | -6.8% | +16.7% | -28.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.